Skip to main content
Contact Us
Subscribe
E-Edition
74°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
CureVac N.V. - Ordinary Shares
(NQ:
CVAC
)
5.440
-0.050 (-0.91%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 20, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about CureVac N.V. - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
5 Stocks To Ride The German Market Rally
June 16, 2025
Via
Benzinga
This Sherwin-Williams Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday
June 13, 2025
Via
Benzinga
Market Monitor News June 13 (Oracle UP - Gamestop DOWN)
June 13, 2025
U.S. stocks edge higher as inflation cools, Oracle soars on AI growth, and markets brace for Israel-Iran conflict escalation.
Via
Chartmill
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Interest Rates
Here are the top movers in Thursday's session.
June 12, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
Insights Ahead: CureVac's Quarterly Earnings
April 09, 2025
Via
Benzinga
Why CureVac (CVAC) Stock Is Moving
January 08, 2025
Shares of CureVac fell by 12.3% Wednesday afternoon. The pullback may stem from profit-taking after Tuesday's strong gains driven by rising concerns over U.S. respiratory illnesses.
Via
Benzinga
Let's take a look at the stocks that are in motion in today's session.
June 12, 2025
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
Nasdaq Moves Higher; Oracle Shares Jump After Upbeat Q4 Results
June 12, 2025
Via
Benzinga
BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal
June 12, 2025
BioNTech agreed to buy CureVac for $1.25 billion, expanding its mRNA cancer research and boosting its oncology pipeline.
Via
Benzinga
CureVac, TELUS International, Oracle And Other Big Stocks Moving Higher On Thursday
June 12, 2025
Via
Benzinga
There are notable gap-ups and gap-downs in today's session.
June 12, 2025
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Via
Chartmill
BioNTech To Acquire CureVac In All-Stock Deal Valued At $1.25B: Retail Sees Breakthrough In Cancer Treatment
June 12, 2025
Under the terms of the deal, each CureVac share will be exchanged for approximately $5.46 in BioNTech American depositary shares.
Via
Stocktwits
Exposures
COVID-19
Wondering what's happening in today's pre-market session?
June 12, 2025
Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.
Via
Chartmill
Trump Administration Terminates $590 Million Moderna Bird Flu Vaccine Deal, Dismantling Biden-Era Pandemic Preparedness Effort
May 29, 2025
The Trump administration terminated a nearly $600 million award to Moderna for developing an mRNA-based bird flu vaccine, ending a key Biden-era pandemic preparedness initiative. The cancellation...
Via
Benzinga
Topics
Government
Exposures
Political
CureVac (CVAC) Stock Rises After Q1 Update, Oncology Pipeline Gains Traction
May 20, 2025
CureVac stock surged after reporting Q1 2025 results and a positive pipeline update. The biotech firm narrowed its operating loss, and cash is expected to fund operations through 2028.
Via
Benzinga
CureVac Stock Declines On Weaker-Than-Expected Q4 Revenue: Retail’s On Wait-And-Watch Mode
April 10, 2025
The company reported revenue of €14.5 million for the fourth quarter, representing a decrease of €8.1 million from the corresponding period of 2023, and below an analyst estimate of €20.58, according...
Via
Stocktwits
Topics
Government
Exposures
Political
Earnings Scheduled For April 10, 2025
April 10, 2025
Via
Benzinga
Traders are paying attention to the gapping stocks in Friday's session.
March 28, 2025
Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.
Via
Chartmill
Top movers in Friday's pre-market session
March 28, 2025
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
Argan Posts Upbeat Results, Joins KULR Technology, Abacus Global Management, W. R. Berkley And Other Big Stocks Moving Higher On Friday
March 28, 2025
Via
Benzinga
European Patent Office Rules Vaccine Developer CureVac's Amended Patent Valid, Stock Jumps
March 28, 2025
CureVac's amended patent survives BioNTech's challenge as EPO upholds validity. A German court will decide on infringement in July 2025.
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Wondering what's happening in today's after-hours session?
March 27, 2025
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch
February 10, 2025
A Nevada dairy worker who initially tested positive for bird flu is currently experiencing mild symptoms, including "pink eye."
Via
Benzinga
Trump Administration Halts All Communications From The Centers For Disease Control As Bird Flu Spreads
January 24, 2025
As the bird flu virus continues to spread through the United States, the Trump administration on Tuesday ordered all communications from the Centers for Disease Control and Prevention to stop.
Via
Benzinga
Topics
Government
Exposures
Political
Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine
January 21, 2025
According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of bird flu in the U.S. and one death associated with the virus.
Via
Benzinga
Bird Flu Raising Red Flags Among Health Officials, CDC Urges Faster Testing
January 16, 2025
The CDC issued a health advisory Thursday recommending that hospitalized patients who have tested positive for influenza be tested for the bird flu virus within 24 hours.
Via
Benzinga
Why CureVac (CVAC) Shares Are Volatile
January 10, 2025
CureVac shares have been volatile over the past week, gaining some 25%. The stock has seen increased trading volume following the U.S.'s first human death from H5N1 bird flu.
Via
Benzinga
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
January 08, 2025
Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.
Via
Benzinga
Topics
ETFs
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally
January 07, 2025
The Louisiana Department of Health on Monday reported the first human death in the U.S. related to the H5N1 bird flu virus. The CDC is also reporting high levels of acute respiratory illnesses...
Via
Benzinga
Why CureVac (CVAC) Stock Is Rising
January 06, 2025
Shares of CureVac are trading higher by 15% during Monday's session. The stock is gaining following a CDC report highlighting a significant increase in acute respiratory illnesses nationwide.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.